Meanwhile, 14 lectins (e.g., PTL-II, LCA, and SJA) revealed noticeable alterations in the BALF glycopatterns between the control group and lung cancer patients at different stages, and the validation results of lectin blotting were generally consistent with the results from lectin microarrays. The gene discussed is HSPG2; the disease is lung cancer.